WAT Medical

WAT Medical Enterprise Ltd. is a Canadian medical technology company specializing in the development of innovative, non-invasive neuromodulation devices. Headquartered in Vancouver, the company focuses on wearable solutions for common health conditions such as nausea, migraine, and obesity. Their flagship products, including EmeTerm and HeadaTerm, utilize targeted electrical stimulation technologies like Transcutaneous Electrical Acupoint Stimulation (TEAS) and Transcutaneous Trigeminal Nerve Stimulation (eTNS) to provide drug-free relief. The company's technology is clinically validated and has received regulatory clearances from the FDA, CE, and Health Canada. WAT Medical aims to improve patient quality of life through accessible and effective digital health technologies.